Similar to the analysis performed 7 days after the first boost (Fig. 2, Supplementary Fig. 3), both HPV-E7- (Supplementary Fig. 10b–e) and VSV-N- (Supplementary Fig. 10f–i) specific CD8+ T cells were more abundant within the tumor (Supplementary Fig. 10d, e, h, i) compared to the periphery (Supplementary Fig. 10b, c, f, g), irrespective of the vaccine regimen. This evidence concerns the gene CD8A and neoplasm.